title: Systemic treatment of severe psoriasis.
abstract: Severe psoriasis presents a difficult therapeutic challenge. Some modalities such as synthetic retinoids, phototherapy and methotrexate have been available for many years and need reappraisal, cyclosporin has only recently become available and requires careful administration. In this article we focus on the therapeutic modalities available to the dermatologist in Australia.
authors.affiliation: University of New South Wales, Sydney, Australia.
authors.forename: K E
authors.initials: KE
authors.lastname: Georgouras
authors.forename: S S
authors.initials: SS
authors.lastname: Zagarella
authors.forename: G D
authors.initials: GD
authors.lastname: Cains
authors.forename: P J
authors.initials: PJ
authors.lastname: Brown
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D010789:Phototherapy; D011379:Prognosis; D011565:Psoriasis / Q000628:therapy*; D012176:Retinoids / Q000627:therapeutic use*; D012720:Severity of Illness Index
chemical_list: D007166:Immunosuppressive Agents; D012176:Retinoids; D016572:Cyclosporine; D008727:Methotrexate